未登录.png)
分享.png)
收藏分享 收藏 Clinical Utility of a Prognostic Scoring System Based on LDH and CRP in HCC Patients Receiving Atezolizumab Plus Bevacizumab基于LDH和CRP的预后评分系统在应用阿替利珠单抗联合贝伐珠单抗治疗的HCC患者中的临床应用价值
Tanaka, Kazunari; Tsuji, Kunihiko; Hiraoka, Atsushi; Tada, Toshifumi; Hirooka, Masashi; Kariyama, Kazuya; Tani, Joji; Atsukawa, Masanori; Takaguchi, Koichi; Itobayashi, Ei; Fukunishi, Shinya; Ishikawa, Toru; Tajiri, Kazuto; Ohama, Hideko; Toyoda, Hidenori; Ogawa, Chikara; Nishimura, Takashi; Hatanaka, Takeshi; Kakizaki, Satoru; Kawata, Kazuhito; Naganuma, Atsushi; Kosaka, Hisashi; Matono, Tomomitsu; Kuroda, Hidekatsu; Yata, Yutaka; Nishikawa, Hiroki; Imai, Michitaka; Aoki, Tomoko; Ochi, Hironori; Kanayama, Yuki; Tada, Fujimasa; Nakamura, Shinichiro; Nouso, Kazuhiro; Morishita, Asahiro; Itokawa, Norio; Okubo, Tomomi; Arai, Taeang; Tsutsui, Akemi; Tanaka, Hironori; Noritake, Hidenao; Kaibori, Masaki; Hiasa, Yoichi; Kudo, Masatoshi; Kumada, Takashi 分享 收藏 Efficacy and Safety of Durvalumab Plus Tremelimumab in Hepatocellular Carcinoma Patients With Portal Vein Thrombosis and High Tumor Burden: A Multicenter Retrospective Analysis度鲁特玛联合特瑞普利单抗在合并门静脉血栓和高肿瘤负荷的肝细胞癌患者中的有效性与安全性：一项多中心回顾性分析Hatanaka, Takeshi; Yata, Yutaka; Hiraoka, Atsushi; Tada, Toshifumi; Hirooka, Masashi; Kariyama, Kazuya; Tani, Joji; Atsukawa, Masanori; Takaguchi, Koichi; Itobayashi, Ei; Kakizaki, Satoru; Fukunishi, Shinya; Tsuji, Kunihiko; Ishikawa, Toru; Tajiri, Kazuto; Toyoda, Hidenori; Koshiyama, Yuichi; Ogawa, Chikara; Nishikawa, Hiroki; Nishimura, Takashi; Kawata, Kazuhito; Kosaka, Hisashi; Matsui, Kosuke; Naganuma, Atsushi; Tanaka, Hironori; Ohama, Hideko; Kuroda, Hidekatsu; Matono, Tomomitsu; Aoki, Tomoko; Ochi, Hironori; Imai, Michitaka; Nakamura, Shinichiro; Komatsu, Shohei; Tamai, Hideyuki; Okamura, Jumpei; Kanayama, Yuki; Tanaka, Kazunari; Tada, Fujimasa; Yoshida, Osamu; Nouso, Kazuhiro; Morishita, Asahiro; Tsutsui, Akemi; Nagano, Takuya; Itokawa, Norio; Okubo, Tomomi; Arai, Taeang; Matsuura, Takanori; Noritake, Hidenao; Enomoto, Hirayuki; Kaibori, Masaki; Fukumoto, Takumi; Hiasa, Yoichi; Kudo, Masatoshi; Kumada, Takashi 分享 收藏 分享 收藏 分享 收藏 Impact of time-of-day atezolizumab plus bevacizumab combination therapy infusion for unresectable hepatocellular carcinoma: A retrospective multicenter studyNaganuma, Atsushi; Kakizaki, Satoru; Hatanaka, Takeshi; Hiraoka, Atsushi; Tada, Toshifumi; Hirooka, Masashi; Kariyama, Kazuya; Tani, Joji; Atsukawa, Masanori; Takaguchi, Koichi; Itobayashi, Ei; Fukunishi, Shinya; Tsuji, Kunihiko; Ishikawa, Toru; Tajiri, Kazuto; Toyoda, Hidenori; Koshiyama, Yuichi; Ogawa, Chikara; Nishikawa, Hiroki; Nishimura, Takashi; Kawata, Kazuhito; Kosaka, Hisashi; Matsui, Kosuke; Yata, Yutaka; Tanaka, Hironori; Ohama, Hideko; Kuroda, Hidekatsu; Matono, Tomomitsu; Aoki, Tomoko; Ochi, Hironori; Imai, Michitaka; Nakamura, Shinichiro; Kanayama, Yuki; Tanaka, Kazunari; Tada, Fujimasa; Yoshida, Osamu; Nouso, Kazuhiro; Morishita, Asahiro; Tsutsui, Akemi; Nagano, Takuya; Itokawa, Norio; Okubo, Tomomi; Arai, Taeang; Enomoto, Hirayuki; Kaibori, Masaki; Hiasa, Yoichi; Kudo, Masatoshi; Kumada, Takashi 分享 收藏 Possible Use of Body Surface Area Value for Estimating Skeletal Muscle Mass in Chronic Liver DiseaseYoh, Kazunori; Nishimura, Takashi; Ikeda, Naoto; Takashima, Tomoyuki; Aizawa, Nobuhiro; Yuri, Yukihisa; Kimura, Taro; Yoshihara, Kohei; Yoshioka, Ryota; Kawata, Shoki; Kawase, Yuta; Nakano, Ryota; Shiomi, Hideyuki; Fukunishi, Shinya; Shinzaki, Shinichiro; Nishiguchi, Shuhei; Enomoto, Hirayuki 分享 收藏 Survival Outcomes Associated With Radiological Progressive Disease Subtypes in Patients With Atezolizumab and Bevacizumab-Treated HCCMatono, Tomomitsu; Tada, Toshifumi; Kumada, Takashi; Hiraoka, Atsushi; Hirooka, Masashi; Kariyama, Kazuya; Tani, Joji; Atsukawa, Masanori; Takaguchi, Koichi; Itobayashi, Ei; Fukunishi, Shinya; Nishikawa, Hiroki; Tanaka, Kazunari; Tsuji, Kunihiko; Ishikawa, Toru; Tajiri, Kazuto; Koshiyama, Yuichi; Toyoda, Hidenori; Ogawa, Chikara; Hatanaka, Takeshi; Kakizaki, Satoru; Kawata, Kazuhito; Ohama, Hideko; Tada, Fujimasa; Nouso, Kazuhiro; Morishita, Asahiro; Tsutsui, Akemi; Nagano, Takuya; Itokawa, Norio; Okubo, Tomomi; Arai, Taeang; Nishimura, Takashi; Imai, Michitaka; Kosaka, Hisashi; Naganuma, Atsushi; Aoki, Tomoko; Kuroda, Hidekatsu; Yata, Yutaka; Nakamura, Yoshiko; Yoshida, Osamu; Nakamura, Shinichiro; Enomoto, Hirayuki; Kaibori, Masaki; Hiasa, Yoichi; Kudo, Masatoshi 分享 收藏 Reliable Performance of mALBI Grade-Based Risk Models for Predicting the Prognosis of Patients With Hepatocellular Carcinoma Receiving Atezolizumab Plus Bevacizumab as First-Line Treatment: Comparative Analysis of 13 Risk ModelsHatanaka, Takeshi; Kakizaki, Satoru; Hiraoka, Atsushi; Tada, Toshifumi; Hirooka, Masashi; Kariyama, Kazuya; Tani, Joji; Atsukawa, Masanori; Takaguchi, Koichi; Itobayashi, Ei; Fukunishi, Shinya; Tsuji, Kunihiko; Ishikawa, Toru; Tajiri, Kazuto; Toyoda, Hidenori; Ogawa, Chikara; Nishikawa, Hiroki; Nishimura, Takashi; Kawata, Kazuhito; Kosaka, Hisashi; Naganuma, Atsushi; Yata, Yutaka; Ohama, Hideko; Kuroda, Hidekatsu; Matono, Tomomitsu; Tanaka, Kazunari; Tada, Fujimasa; Nouso, Kazuhiro; Morishita, Asahiro; Tsutsui, Akemi; Nagano, Takuya; Itokawa, Norio; Okubo, Tomomi; Arai, Taeang; Imai, Michitaka; Koizumi, Yohei; Nakamura, Shinichiro; Kaibori, Masaki; Iijima, Hiroko; Hiasa, Yoichi; Kumada, Takashi 分享 收藏 Efficacy of durvalumab plus tremelimumab treatment for unresectable hepatocellular carcinoma in immunotherapy era clinical practice免疫治疗时代临床实践中durvalumab联合tremelimumab治疗不可切除肝细胞癌的疗效Hiraoka, Atsushi; Tada, Toshifumi; Hirooka, Masashi; Kariyama, Kazuya; Tani, Joji; Atsukawa, Masanori; Takaguchi, Koichi; Itobayashi, Ei; Fukunishi, Shinya; Tsuji, Kunihiko; Ishikawa, Toru; Tajiri, Kazuto; Ohama, Hideko; Toyoda, Hidenori; Ogawa, Chikara; Nishimura, Takashi; Hatanaka, Takeshi; Kakizaki, Satoru; Kawata, Kazuhito; Naganuma, Atsushi; Kosaka, Hisashi; Matono, Tomomitsu; Kuroda, Hidekatsu; Yata, Yutaka; Nishikawa, Hiroki; Imai, Michitaka; Aoki, Tomoko; Ochi, Hironori; Tada, Fujimasa; Nakamura, Shinichiro; Nakamura, Yoshiko; Nouso, Kazuhiro; Morishita, Asahiro; Itokawa, Norio; Okubo, Tomomi; Arai, Taeang; Tsutsui, Akemi; Nagano, Takuya; Tanaka, Kazunari; Tanaka, Hironori; Koshiyama, Yuichi; Kanayama, Yuki; Noritake, Hidenao; Enomoto, Hirayuki; Kaibori, Masaki; Hiasa, Yoichi; Kudo, Masatoshi; Kumada, Takashi 分享 收藏 Feasibility of Double-Deployment Small-Diameter Covered Metallic Stent for Malignant Distal Biliary Obstruction (with Video)Nakano, Ryota; Shiomi, Hideyuki; Okamoto, Mamiko; Kawase, Yuta; Yoshihara, Kohei; Yoshioka, Ryota; Kawata, Shoki; Yuri, Yukihisa; Takashima, Tomoyuki; Aizawa, Nobuhiro; Ikeda, Naoto; Nishimura, Takashi; Fukunishi, Shinya; Enomoto, Hirayuki 分享 收藏 A classification model for resectability in hepatocellular carcinoma patientsNakamura, Ikuo; Yoh, Tomoaki; Nishimura, Takashi; Okuno, Masayuki; Okamoto, Tomohiro; Sueoka, Hideaki; Iida, Kenjiro; Tada, Masaharu; Ishii, Takamichi; Seo, Satoru; Fujimoto, Yasuhiro; Iijima, Hiroko; Hirono, Seiko; Hatano, Etsuro 分享 收藏 Predictive factors and survival outcome of conversion therapy for unresectable hepatocellular carcinoma patients receiving atezolizumab and bevacizumab: Comparative analysis of conversion, partial response and complete response patientsHatanaka, Takeshi; Kakizaki, Satoru; Hiraoka, Atsushi; Tada, Toshifumi; Hirooka, Masashi; Kariyama, Kazuya; Tani, Joji; Atsukawa, Masanori; Takaguchi, Koichi; Itobayashi, Ei; Fukunishi, Shinya; Tsuji, Kunihiko; Ishikawa, Toru; Tajiri, Kazuto; Toyoda, Hidenori; Ogawa, Chikara; Nishikawa, Hiroki; Nishimura, Takashi; Kawata, Kazuhito; Kosaka, Hisashi; Naganuma, Atsushi; Yata, Yutaka; Ohama, Hideko; Kuroda, Hidekatsu; Matono, Tomomitsu; Aoki, Tomoko; Kanayama, Yuki; Tanaka, Kazunari; Tada, Fujimasa; Nouso, Kazuhiro; Morishita, Asahiro; Tsutsui, Akemi; Nagano, Takuya; Itokawa, Norio; Okubo, Tomomi; Arai, Taeang; Imai, Michitaka; Nakamura, Shinichiro; Enomoto, Hirayuki; Kaibori, Masaki; Hiasa, Yoichi; Kudo, Masatoshi; Kumada, Takashi 分享 收藏 分享 收藏 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
